BioCryst Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

BCRX 11.58 -0.60 (-4.93%)
price chart
BioCryst And NewLink Surge On Latest US Ebola Case
BioCryst Pharmaceuticals, Inc. (BCRX) surged 14.7% yesterday following news that a nurse, who had been in direct physical contact with Thomas Duncan, had also contracted Ebola.
Small Cap Biotech Game Changers: NewLink Genetics Corp (NASDAQ:NLNK ...  StreetWise Report
Biotech Gainers: Arrowhead Research Corp. (NASDAQ:ARWR), BioCryst ...  WallStreet Scope
Related articles »  
Reaction to Confirmed Ebola Case in U.S. � UPDATED
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) was up 5% at $9.78 in the after-hours, but that was after a 6.7% drop to $9.78 in regular trading.
Morning Buzz: Tekmira Pharmaceuticals (TKMR), Biocryst Pharmaceuticals ...  Wall Street Pit
Biocryst Pharmaceuticals Inc. (BCRX) Is Rising After U.S. Ebola Case Confirmed  RTT News
Related articles »  
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7%
BioCryst Pharmaceuticals, Inc. (BCRX - Snapshot Report) was a big mover last session with its shares rising nearly 15% on the day.
BioCryst Pharmaceuticals Inc. (BCRX) Has Broken Out Of Today's Range
(RTTNews.com) - BioCryst Pharmaceuticals Inc. ( BCRX ) has been trading in a range since the open Tuesday, but has broken out higher in the last few minutes on increased volume.
Related articles »  
Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
Heavy Early Morning Activity On Biocryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
Why Investors Are Tracking: BioCryst Pharmaceuticals (NASDAQ:BCRX ...  WallStreet Scope
Related articles »  
Key Updates: 8x8, Inc. (EGHT), BioCryst Pharmaceuticals (BCRX), Sarepta ...
The Ebola infection story has caught up with the stock of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), but in a positive way.
Related articles »  
Weakness Seen in BioCryst Pharmaceuticals (BCRX): Stock Tumbles 8.0%
BioCryst Pharmaceuticals, Inc. (BCRX - Snapshot Report) saw a big move last session, as the company's shares fell by nearly 8% on the day.
Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases.
Related articles »  
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 12.4% - Tale of the Tape
BioCryst Pharmaceuticals, Inc. ( BCRX ) was a big mover last session, as the company shares rose over 12% on the day.
Related articles »